Rang	Name	Position
1	Mr. David A. Ricks	Chairman & CEO
2	Mr. Lucas E. Montarce	Executive VP & CFO
3	Dr. Daniel M. Skovronsky M.D., Ph.D.	Chief Scientific & Product Officer and President of Lilly Research Laboratories
4	Ms. Anat Hakim J.D.	Executive VP, General Counsel & Secretary
5	Mr. Jacob S. Van Naarden	Executive VP, President of Lilly Oncology & Head of Corporate Business Development
6	Mr. Donald A. Zakrowski	Senior VP of Finance & Chief Accounting Officer
7	Mr. Diogo Rau	Executive VP and Chief Information & Digital Officer
8	Mr. Michael Czapar	Director of Investor Relations
9	Mr. Eric Dozier	Executive VP & Chief People Officer
10	Mr. Ilya Yuffa	Executive VP and President of Lilly USA & Global Customer Capabilities

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Lilly Endowment Inc	10,13%	107,18 Mrd. USD
2	Vanguard Group Inc	9,19%	97,20 Mrd. USD
3	BlackRock Inc	7,44%	78,72 Mrd. USD
4	Vanguard Capital Management, LLC	5,98%	63,28 Mrd. USD
5	PNC Financial Services Group Inc	5,76%	60,87 Mrd. USD
6	State Street Corp	3,99%	42,23 Mrd. USD
7	FMR Inc	2,95%	31,24 Mrd. USD
8	Capital Research Global Investors	2,76%	29,21 Mrd. USD
9	Vanguard Portfolio Management, LLC	2,35%	24,88 Mrd. USD
10	Geode Capital Management, LLC	2,26%	23,95 Mrd. USD
11	Capital World Investors	1,75%	18,53 Mrd. USD
12	Morgan Stanley - Brokerage Accounts	1,73%	18,31 Mrd. USD
13	T. Rowe Price Associates, Inc.	1,57%	16,59 Mrd. USD
14	JPMorgan Chase & Co	1,54%	16,25 Mrd. USD
15	Wellington Management Company LLP	1,51%	15,92 Mrd. USD
16	NORGES BANK	1,35%	14,32 Mrd. USD
17	Bank of America Corp	1,25%	13,19 Mrd. USD
18	State Farm Mutual Automobile Ins Co	1,21%	12,76 Mrd. USD
19	PRIMECAP Management Company	1,03%	10,94 Mrd. USD
20	Northern Trust Corp	0,99%	10,47 Mrd. USD